Myelomeningocele: A Brazilian University Hospital experience

Arquivos de Neuro-Psiquiatria

Volumn 62, Issue 4, 2004, Pages 963-968

  Ulsenheimer, Maria M M ^a   Antoniuk, Sérgio A ^a   Dos Santos, Lucia H C ^a   Ceccatto, Marcos P ^a   Da Silveira, Antônio Ernesto ^a   Ruiz, Ana Paula ^b   Egger, Paulo ^b   Bruck, Isac ^a,b  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^b Departamento de Cirurgia da UFPR ^*

Author keywords

Meningomyelocele; Neural tube defects; Neurological disabilities

Indexed keywords

ARTICLE; BACK; BRAZIL; CESAREAN SECTION; CHILD; CHILD DEATH; CLINICAL ARTICLE; CLUBFOOT; DIABETES MELLITUS; EPILEPSY; FEMALE; FOLLOW UP; FOOT MALFORMATION; HUMAN; HYDROCEPHALUS; MALE; MEMBRANE RUPTURE; MENINGITIS; MENINGOMYELOCELE; MOTOR DEVELOPMENT; NEUROGENIC BLADDER; PRENATAL DIAGNOSIS; QUALITY OF LIFE; SHUNTING; UNIVERSITY HOSPITAL;

EID: 10944255517     PISSN: 0004282X     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0004-282X2004000600006     Document Type: Article

References (29)

1. Grillo E, Silva RJM. Defeitos do tubo neural e hidrocefalia congênita: par que conhecer suas prevalências? J Pediatria 2003;79:105-106.
2. Nordirup H, Volcik KA. Spina bifida and other neural tube defects. Curr Probl Pediatr 2000;30:315-337.
3. Aguiar MJB, Campos AS, Aguiar RALP, et al. Defeitos de fechamento do tubo neural e fatores associados em recém-nascidos vivos e natimortos. J Pediatria 2003;79:129-134.
4. Czeizel AE, Dudas I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 1992;327:1832-1835.
5. Czeizel A E. Prevention of congenital abnormalities by periconceptional multivitamin supplementation. BMJ 1993;306:1645-1648.
6. Werler MM, Shapiro S, Mitchell AA. Periconceptional folic acid exposure and risk of ocurrent neural tube defects. JAMA 1993;269:1257-1261.
7. Daly S, Mills JL, Molloy AM, Conley M, Lee YJ. Minimum effective dose of folk acid for food fortification to prevent neural-tube defects. Lancet 1997;350:1666-1669.
8. Kadir RZ, Sabin C, Whitlow B, Brockbank E, Economides D. Neural tube defects and periconceptional folic acid in England and Wales: retrospective study. BMJ 1999;319:92-93.
9. Glascoe FP, Byrne KE, Ashford LG, Johnson KL, Chang B, Strickland B. Accuracy of the Denver II in developmental screening. Pediatrics 1992;89:1221-1225.
10. Frankenburg WK, Dodds J, Archer P, Shapiro H, Bresnick B. The Denver II: a major revision and restandardization of the Denver Developmental Screeneing Test. Pediatrics 1992;89:91-97.
11. Greene WB, Terry RC, DeMasi RA, Herrington RT. Effect of race and gender on neurological level in myelomeningocele. Dev Med Child Neurol 1991;33:110-117.
12. Charney EB, Melchionni JB, Smith DR. Community ambulation by children with myelomeningocele and high-level paralysis. J Pediatr Orthop 1991;11:579-582.
13. Bier JB, Morales Y, Liebling J, Geddes L, Kim E. Medical and social factors associated with cognitive outcome in individuals with myelomeningocele. Dev Med Child Neurol 1997;39:263-266.
14. Dumas JL, Pascaud E, Novelle G, Ronayette D, Rousseau J. Place de l' écho-encéphalographie dans les myéloméningoceles. Ann Pédiatr (Paris) 1992;39:53-55.
15. Skari H, Bjornland K, Bjornstad-Ostensen A, Haugen G, Emblem R. Consequences of prenatal diagnosis: a preliminary report on neonates with congenital malformations. Acta Obstet Gynecol Scand 1998;77:635-642.
16. Merril DC, Goodwin P, Burson JM, Sato Y, Williamsom R, Weiner CP. The optimal route of delivery for fetal meningomyelocele. Am J Obstet Gynecol 1998;179:235-240.
17. Hill AE, Beattie F. Does cesarean section delivery improve neurological outcome in open spina bifida? Eur J Pediatr Surg 1994;4(Suppl 1):S32-S34.
18. Comitee on Fetus and Newborn of American Academy of Pediatrics and Comitee on Obstetric Practice of American College of Obstetricians and Gynecologists. Use and abuse of the Apgar Score. Pediatrics 1996;98:141-142.
19. Rolle U, Gräfe G. About the rate of shunt complications in patients with hydrocephalus and myelomeningocele. Eur J Pediatr Surg 1999;9(Suppl 1):S51-S52.
20. Brau RH, Rodríguez R, Ramirez MV, González R, Martínez V. Experience in the management of myelomeningocele in Puerto Rico. J Neurosurg 1990;72:726-731.
21. Fobe J, Rizzo AMPP, Silva IM et al. QI em pacientes com hidrocefalia e mielomeningocele. Arq Neuropsiquiatr 1999;57:44-50.
22. Charney EB, Melchionni JB, Antonucci D. Ventriculitis in newborns with myelomeningocele. AJDC 1991;145:287-290.
23. Hack CH, Enrile BG, Donat JF, Kosnik E. Seizures in relation to shunt dysfunction in children with meningomyelocele. J Pediatr 1990;116:57-60.
24. Noetzel MJ, Blake JN. Prognosis for seizure control and remission in children with myelomeningocele. Dev Med Child Neurol 1991;33:803-810.
25. Talwar D, Baldwin MA, Horbatt CI. Epilepsy in children with meningomyelocele. Pediatr Neurol 1995;13:29-32.
26. Churchill BM, Abramson RP, Wahl EF. Dysfunction of the lower urinary and distal gastrointestinal tracts in pediatric patients with know spinal cord problems. Pediatr Urol 2001;48:1587-1629.
27. Kaefer M, Pabby A, Kelly M, Darbey M, Bauer SB. Improved bladder function after prophylactic treatment of the high risk neurogenic bladder in newborns with myelomeningocele. J Urol 1999;126:1068-1071.
28. Wu H, Baskin LS, Kogan BA. Neurogenic bladder dysfunction due to myelomeningocele: neonatal versus childhood treatment. J Urol 1997;157:2295-2297.
29. Agenda Nacional de Vigilância Sanitária. Resolução - RDC n° 344, de 13 de dezembro de 2002. Diário Oficial da União de 18/12/2002. http://www.anvisa.gov.br/ legis/resol/2002/344_02rdc.htm.